Zobrazeno 1 - 10
of 47
pro vyhledávání: '"D. P. J. Barton"'
Autor:
P. I. Stanciu, T. E. J. Ind, D. P. J. Barton, J. B. Butler, K. M. Vroobel, A. D. Attygalle, M. A. E. Nobbenhuis
Publikováno v:
Journal of Ovarian Research, Vol 12, Iss 1, Pp 1-6 (2019)
Abstract Introduction The management of Serous Tubal Intraepithelial Carcinoma (STIC) found at the time of Risk-Reducing Salpingo-Oophorectomy (RRSO) remains unclear. We set out to analyse the incidence of peritoneal carcinomas developed after prophy
Externí odkaz:
https://doaj.org/article/672ec42d23614213930a1e7bb9005370
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2018 (2018)
Sertoli-Leydig cell tumours of the ovary (SLCT) are rare tumours predominantly caused by mutations in the DICER1 gene. We present a patient with a unilateral SLCT who had an underlying germline DICER1 gene mutation. We discuss the underlying patholog
Externí odkaz:
https://doaj.org/article/f710535dd04e4c66994ac1aae733f5c1
Autor:
Marielle Nobbenhuis, Aslam Sohaib, D. P. J. Barton, V Seebacher, Andrea Rockall, John H. Shepherd
Publikováno v:
Geburtshilfe und Frauenheilkunde. 77:396-405
Publikováno v:
ePoster.
Introduction/Background The main goal of pelvic exenteration (PEx) for recurrent cancer is to achieve cure. This is most strongly associated with R0 resection, which is also associated with prolonged disease-free interval. Patients typically have bee
Autor:
S Bryan, G Imseeh, Aslam Sohaib, J Ash, Desiree F. Kolomainen, NM de Souza, D. P. J. Barton, A Taylor, A Fernandes
Publikováno v:
Poster exhibition Day 1.
Introduction/Background Pelvic exenteration (PE) can provide long-term survival for patients with recurrent gynaecological malignancies, but there is a high risk of relapse. To develop evidence-based strategies for post-operative treatment, this stud
Autor:
Marielle Nobbenhuis, S Bryan, N Mcaddy, E Tsahalina, Aslam Sohaib, Thomas Ind, D. P. J. Barton, John Butler
Publikováno v:
ePoster.
Introduction/Background Aim: To identify 12 radiological criteria predictors of complete secondary cytoreductive surgery to assist case selection. Methodology This is a retrospective review of all recurrent cases of ovarian, fallopian tube and perito
Publikováno v:
Poster exhibition Day 2.
Introduction/Background Surgical margin status is a strong prognostic indicator of disease free and overall survival following pelvic exenteration (PE) for recurrent gynaecological malignancy. There have been few attempts at post-operative treatment
Publikováno v:
Oral Communication 4 – Gynaecological Cancer.
Introduction/Background Pelvic exenteration (PE) can result in considerable acute and long-term morbidity. Routine longitudinal assessment of quality of life (QoL) of women with recurrent/persistent gynaecological cancer undergoing/had undergone PE,
Autor:
D. P. J. Barton, P. I. Stanciu, Thomas Ind, Marielle Nobbenhuis, Ayoma D. Attygalle, Katherine Vroobel, John Butler
Publikováno v:
Journal of Ovarian Research, Vol 12, Iss 1, Pp 1-6 (2019)
Journal of Ovarian Research
Journal of Ovarian Research
Introduction The management of Serous Tubal Intraepithelial Carcinoma (STIC) found at the time of Risk-Reducing Salpingo-Oophorectomy (RRSO) remains unclear. We set out to analyse the incidence of peritoneal carcinomas developed after prophylactic su
Autor:
J. Hunt, R. Swindell, Michelle L. MacKintosh, D. P. J. Barton, R. Rahim, Bilal H. Kirmani, B. Rajashanker, R. D. Clayton, E. Brockbank
Publikováno v:
Journal of Obstetrics and Gynaecology. 34:424-428
Our aim was to design and validate a model of CT findings that predict suboptimal cytoreduction in primary surgery (PS) for Stage III–IV epithelial ovarian cancer (EOC). We performed a retrospective review of preoperative CT scans of patients under